NORTHWEST BIOTHERAPEUTICS INC Deferred Foreign Income Tax Expense (Benefit)
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Deferred Foreign Income Tax Expense (Benefit) of $2.96 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-04-15
- NORTHWEST BIOTHERAPEUTICS INC deferred foreign income tax expense (benefit) for fiscal 2025 was $2.96M.
- NORTHWEST BIOTHERAPEUTICS INC deferred foreign income tax expense (benefit) for fiscal 2024 was -$1.42M, a 7563.16% decline from fiscal 2023.
- NORTHWEST BIOTHERAPEUTICS INC deferred foreign income tax expense (benefit) for fiscal 2023 was $19.00K.
- NORTHWEST BIOTHERAPEUTICS INC deferred foreign income tax expense (benefit) for fiscal 2022 was -$489.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $2.96M 10-K · filed 2026-04-15 | |
| 2024-12-31 | -$1.42M 10-K · filed 2026-04-15 | |
| 2023-12-31 | $19.00K 10-K · filed 2025-03-31 | |
| 2022-12-31 | -$489.00K 10-K · filed 2024-03-05 | |
| 2021-12-31 | -$599.00K 10-K · filed 2023-02-28 | |
| 2020-12-31 | $670.00K 10-K · filed 2022-03-01 | |
| 2019-12-31 | -$404.00K 10-K · filed 2021-03-31 | |
| 2018-12-31 | -$1.87M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $924.00K 10-K · filed 2019-04-02 | -$924.00K 10-K · filed 2018-04-17 |
| 2016-12-31 | -$5.19M 10-K · filed 2018-04-17 | |
| 2015-12-31 | $0.00 10-K · filed 2017-04-17 |